Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10590089 | Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide | Indrajit Ghosh, Lianfeng Huang, Daozhong Zou | 2020-03-17 |
| 10131639 | Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methylcyclohexylamino)-pyrimidine-5-carboxamide | Indrajit Ghosh, Lianfeng Huang, Daozhong Zou | 2018-11-20 |
| 10052322 | Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one | Anil Menon, Darshan Parikh, Dora Visky, Thomas Lee, Xiaozhang Liang | 2018-08-21 |
| 9981971 | Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one as TOR kinase inhibitors | — | 2018-05-29 |
| 9884042 | Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide | Wai Yip Thomas Lee, Ho-Wah Hui, Paul Kurtulik | 2018-02-06 |
| 9796685 | Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methylcyclohexylamino)-pyrimidine-5-carboxamide | Indrajit Ghosh, Lianfeng Huang, Daozhong Zou | 2017-10-24 |
| 9403829 | Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use | Terrence Joseph Connolly, Kevin J. Klopfer, William W. Leong, Anil Menon, Amanda Nicole Miklos +7 more | 2016-08-02 |
| 9359364 | Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one | Anil Menon, Darshan Parikh, Dora Visky, Matthew Michael Kreilein, Thomas Lee +5 more | 2016-06-07 |